> ## Content Index
> Fetch the complete content index at: https://www.bullished.co/llms.txt
> Use this file to discover other available public pages before exploring further.

# Prudential's Subsidiaries Hold 5.5% Of Rezolute — Jennison Accounts For Nearly All The Shares
- URL: https://www.bullished.co/prudentials-subsidiaries-hold-5-5-of-rezolute-jennison-accounts-for-nearly-all-the-shares-fb6d6c3d/
- Published: 2026-11-13T20:40:59.000Z
- Updated: 2026-11-13T20:40:59.000Z
- Description: The ownership report dates to September 30, while Rezolute separately priced financing expected to bring about $100 million in gross proceeds.
- Author: Matteo Parrino
- Tags: SEC Filings, RZLT, Industry: Healthcare

Prudential Financial reported Friday that its subsidiaries held a [5.5% passive stake](https://www.sec.gov/Archives/edgar/data/0001137774/000113777426000230/xslSCHEDULE%5F13G%5FX01/primary%5Fdoc.xml?ref=bullished.co) in [Rezolute](https://www.bullished.co/tag/rzlt/), which develops treatments for dangerously low blood sugar caused by excess insulin activity. The SEC ownership disclosure covered September 30 holdings, with Jennison accounting for nearly all the shares.

## Jennison Holds Almost The Entire Position

Prudential, the parent holding company reporting its subsidiaries' ownership, listed 5,344,968 beneficially owned common shares. Jennison held [5,332,068 shares](https://www.sec.gov/Archives/edgar/data/0001137774/000113777426000230/xslSCHEDULE%5F13G%5FX01/primary%5Fdoc.xml?ref=bullished.co), while PGIM Quantitative Solutions, the other subsidiary included in the report, held 12,900.

Prudential certified that the securities were bought and held as part of normal business activity, without an aim to change or influence Rezolute's control.

## Financing For Commercialization Preparations

Rezolute separately [priced an offering](https://www.globenewswire.com/news-release/2026/11/13/3402452/0/en/rezolute-announces-pricing-of-approximately-100-million-underwritten-offering-of-common-stock-and-pre-funded-warrants.html?ref=bullished.co) Friday that it expects to generate approximately $100 million before expenses. The company plans to use the money for commercialization preparations, working capital and general corporate purposes.

Rezolute expects the offering to [close on or about Monday](https://www.globenewswire.com/news-release/2026/11/13/3402452/0/en/rezolute-announces-pricing-of-approximately-100-million-underwritten-offering-of-common-stock-and-pre-funded-warrants.html?ref=bullished.co). Its market value was $374 million in Friday trading.

The company has no approved products. Its lead candidate, ersodetug, is an antibody delivered intravenously and studied for both congenital hyperinsulinism, which affects children, and hyperinsulinism caused by tumors.

## Glucose Support Fell In Tumor Trial

An evaluation on November 5 of Rezolute's late-stage tumor-hyperinsulinism trial found that [13 of 16](https://www.globenewswire.com/news-release/2026/11/13/3402451/0/en/rezolute-announces-positive-results-from-the-phase-3-uplift-study-in-tumor-hyperinsulinism.html?ref=bullished.co) participants needed glucose infused at a rate at least 50% lower. Twelve responders stopped receiving intravenous glucose altogether, though some participants were still in the pivotal study period.

Rezolute also supplies ersodetug through an expanded-access program for patients unable to enter a clinical trial. Research and development spending totaled about $53.8 million in the fiscal year ended June 30, 2026.

Rezolute expects [completed study results](https://www.globenewswire.com/news-release/2026/11/13/3402451/0/en/rezolute-announces-positive-results-from-the-phase-3-uplift-study-in-tumor-hyperinsulinism.html?ref=bullished.co), including the statistical analysis of the trial's main goal, by mid-December 2026.

Learn

- [What a Reverse Termination Fee Means: Who Pays When a Merger Collapses →](https://www.bullished.co/learn/reverse-termination-fee-meaning/)  
A reverse termination fee is paid by the buyer to the target if a merger fails on agreed terms. See how it differs from a break-up fee, with live deal examples.
- [How To Read A Merger Proxy: A Checklist For Shareholders Facing A Vote →](https://www.bullished.co/learn/merger-proxy-statement-how-to-read/)  
Facing a merger vote? Read the proxy in this order: price and payment, vote date and threshold, board background, synergy claims, then closing conditions.

### Sources

- [SCHEDULE 13G — PRUDENTIAL FINANCIAL INC re: Rezolute, Inc. (RZLT)](https://www.sec.gov/Archives/edgar/data/0001137774/000113777426000230/xslSCHEDULE%5F13G%5FX01/primary%5Fdoc.xml?ref=bullished.co) — SEC EDGAR
- [Rezolute Raises $100 Million, Advances Ersodetug Toward Commercialization](https://finance.yahoo.com/healthcare/articles/rezolute-raises-100-million-advances-172742991.html?.tsrc=rss&ref=bullished.co) — Yahoo Finance
- [Rezolute Announces Pricing of Approximately $100 Million](https://www.globenewswire.com/news-release/2026/11/13/3402452/0/en/rezolute-announces-pricing-of-approximately-100-million-underwritten-offering-of-common-stock-and-pre-funded-warrants.html?ref=bullished.co) — globenewswire.com
- [Rezolute Announces Positive Results from the Phase 3 upLIFT](https://www.globenewswire.com/news-release/2026/11/13/3402451/0/en/rezolute-announces-positive-results-from-the-phase-3-uplift-study-in-tumor-hyperinsulinism.html?ref=bullished.co) — globenewswire.com

### More on Rezolute

- [Rezolute Stock Jumps 4% After Preliminary Trial Results Clear The Study's Main Goal](https://www.bullished.co/rezolute-stock-jumps-4-after-preliminary-trial-results-clear-the-studys-main-goal-3b28170f/)
- [Rezolute's Experimental Drug Clears Nine-Responder Trial Threshold With 13 Responders In Preliminary Results](https://www.bullished.co/rezolutes-experimental-drug-clears-nine-responder-trial-threshold-with-13-responders-in-c7018761/)
- [Rezolute Has $90.0 Million In Cash And Investments As Drug Results Approach](https://www.bullished.co/rezolute-has-90-0-million-in-cash-and-investments-as-drug-results-approach-4d39640d/)

[All Rezolute (RZLT) coverage →](https://www.bullished.co/tag/rzlt/)